Dillon & Associates Inc Merck & Co., Inc. Transaction History

Dillon & Associates Inc

  • $688 Million
  • Q2 2024

A detailed history of Dillon & Associates Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Dillon & Associates Inc holds 3,451 shares of MRK stock, worth $386,788. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,451
Previous 3,376 2.22%
Holding current value
$386,788
Previous $446,000 4.04%
% of portfolio
0.06%
Previous 0.07%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024
BUY
$123.8 - $132.96 $9,285 - $9,972
75 Added 2.22%
3,451 $428,000
Q1 2024

Apr 30, 2024
SELL
$113.24 - $131.95 $8,493 - $9,896
-75 Reduced 2.17%
3,376 $446,000
Q4 2023

Feb 08, 2024
SELL
$100.18 - $109.02 $14,526 - $15,807
-145 Reduced 4.03%
3,451 $376,000
Q3 2023

Nov 13, 2023
BUY
$102.95 - $114.33 $7,515 - $8,346
73 Added 2.07%
3,596 $370,000
Q1 2023

May 02, 2023
SELL
$102.94 - $114.86 $170,159 - $189,863
-1,653 Reduced 31.94%
3,523 $373,000
Q1 2023

May 01, 2023
BUY
$102.94 - $114.86 $181,483 - $202,498
1,763 Added 51.66%
5,176 $550,000
Q4 2022

Feb 06, 2023
SELL
$87.44 - $112.11 $437 - $560
-5 Reduced 0.15%
3,413 $379,000
Q2 2022

Jul 26, 2022
SELL
$83.49 - $94.64 $22,959 - $26,026
-275 Reduced 7.45%
3,418 $311,000
Q1 2022

May 06, 2022
SELL
$73.51 - $82.4 $109,015 - $122,199
-1,483 Reduced 28.65%
3,693 $303,000
Q4 2021

Feb 14, 2022
SELL
$72.28 - $90.54 $136,970 - $171,573
-1,895 Reduced 26.8%
5,176 $399,000
Q3 2021

Oct 28, 2021
SELL
$71.68 - $78.83 $343,490 - $377,753
-4,792 Reduced 40.39%
7,071 $530,000
Q2 2021

Aug 02, 2021
SELL
$70.31 - $77.77 $113,550 - $125,598
-1,615 Reduced 11.98%
11,863 $925,000
Q1 2021

May 10, 2021
SELL
$68.86 - $81.11 $18,936 - $22,305
-275 Reduced 2.0%
13,478 $1.04 Million
Q4 2020

Feb 12, 2021
BUY
$71.77 - $79.65 $100,765 - $111,828
1,404 Added 11.37%
13,753 $1.13 Million
Q3 2020

Nov 06, 2020
BUY
$73.18 - $82.95 $44,200 - $50,101
604 Added 5.14%
12,349 $1.03 Million
Q2 2020

Jul 28, 2020
BUY
$70.42 - $80.13 $138,375 - $157,455
1,965 Added 20.09%
11,745 $904,000
Q1 2020

May 07, 2020
BUY
$63.36 - $87.82 $101,059 - $140,072
1,595 Added 19.49%
9,780 $753,000
Q4 2019

Feb 03, 2020
BUY
$77.58 - $87.54 $392,166 - $442,514
5,055 Added 161.5%
8,185 $745,000
Q3 2018

Nov 14, 2018
BUY
$57.69 - $67.84 $180,569 - $212,339
3,130 New
3,130 $222,000
Q4 2017

Feb 08, 2018
SELL
$51.62 - $61.64 $161,570 - $192,933
-3,130 Closed
0 $0
Q2 2017

Aug 09, 2017
BUY
N/A
3,130
3,130 $200,000

Others Institutions Holding MRK

# of Institutions
3,829
Shares Held
1.91B
Call Options Held
13.4M
Put Options Held
10.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $284B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Dillon & Associates Inc Portfolio

Follow Dillon & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dillon & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dillon & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email